Showing results (1731-1740 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|February 28, 2006
Macrophage activation syndrome and other systemic inflammatory conditions after BMTA Sreedharan, S Bowyer, C A Wallace, et al.
Bone Marrow Transplantation|February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre studyA Gonçalves, R Delva, M Fabbro, et al.
Bone Marrow Transplantation|March 7, 2006
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantationV Pavone, F Gaudio, G Console, et al.
Bone Marrow Transplantation|March 15, 2006
Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphomaC Joao, L F Porrata, D J Inwards, et al.
Bone Marrow Transplantation|March 15, 2006
Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantationE Ayala, J Greene, R Sandin, et al.
Bone Marrow Transplantation|March 15, 2006
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantationV T Ho, H T Kim, D Liney, et al.
Bone Marrow Transplantation|May 10, 2005
Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II studyM H Jagasia, J P Greer, D S Morgan, et al.
Bone Marrow Transplantation|May 24, 2005
Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplantsS Damodar, B George, J Mammen, et al.
Bone Marrow Transplantation|April 27, 2005
Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioningS Yoshihara, U Tateishi, T Ando, et al.
Bone Marrow Transplantation|June 22, 2005
Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host diseaseL Giaccone, P Martin, P Carpenter, et al.
Pageof 993